LENSAR, Inc. (NASDAQ:LNSR) Short Interest Down 21.9% in March

LENSAR, Inc. (NASDAQ:LNSR - Get Free Report) saw a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 108,200 shares, a decrease of 21.9% from the March 15th total of 138,600 shares. Based on an average trading volume of 162,800 shares, the short-interest ratio is presently 0.7 days. Currently, 1.2% of the company's stock are sold short.

Wall Street Analysts Forecast Growth

LNSR has been the subject of several research analyst reports. BTIG Research lowered shares of LENSAR from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 24th. Lake Street Capital reiterated a "hold" rating and issued a $15.00 price objective (down from $16.00) on shares of LENSAR in a report on Monday, March 24th.

LENSAR Price Performance

NASDAQ LNSR traded up $0.03 on Thursday, hitting $13.87. 77,284 shares of the company's stock were exchanged, compared to its average volume of 70,319. LENSAR has a fifty-two week low of $2.95 and a fifty-two week high of $17.31. The firm's 50-day moving average price is $13.41 and its two-hundred day moving average price is $9.72. The firm has a market cap of $163.51 million, a price-to-earnings ratio of -9.49 and a beta of 0.56.

LENSAR (NASDAQ:LNSR - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported ($1.61) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($1.40). LENSAR had a negative net margin of 34.03% and a negative return on equity of 49.02%. The company had revenue of $16.73 million during the quarter, compared to analyst estimates of $14.95 million.

Hedge Funds Weigh In On LENSAR

Several institutional investors and hedge funds have recently added to or reduced their stakes in LNSR. Geode Capital Management LLC raised its holdings in shares of LENSAR by 3.5% during the third quarter. Geode Capital Management LLC now owns 100,431 shares of the company's stock worth $460,000 after acquiring an additional 3,423 shares in the last quarter. Atria Investments Inc increased its position in LENSAR by 28.2% during the fourth quarter. Atria Investments Inc now owns 26,055 shares of the company's stock worth $233,000 after buying an additional 5,729 shares during the last quarter. Essex Investment Management Co. LLC raised its holdings in LENSAR by 18.3% during the fourth quarter. Essex Investment Management Co. LLC now owns 39,890 shares of the company's stock valued at $357,000 after buying an additional 6,184 shares in the last quarter. Evernest Financial Advisors LLC acquired a new stake in shares of LENSAR in the fourth quarter worth about $174,000. Finally, Bailard Inc. acquired a new position in shares of LENSAR during the 4th quarter valued at about $181,000. 40.15% of the stock is currently owned by hedge funds and other institutional investors.

LENSAR Company Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.